Sumitomo Pharma Co Ltd (DPM) Stock Price & News

Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Wikipedia

About Sumitomo Pharma Co Ltd

CEO-

Employees3.12K

FoundedMay 14, 1897

HeadquartersOsaka, Osaka, Japan

SectorPharmaceutical industry

Websitesumitomo-pharma.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	119.12B	120.62B	105.55B	129.50B
Cost of goods sold	45.59B	55.44B	51.26B	61.41B
Cost of revenue	45.59B	55.44B	51.26B	61.41B
Research and development expenses	9.35B	10.35B	16.12B	11.43B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	40.90B	42.94B	43.52B	39.24B
Operating expense	-1.04B	52.19B	110.09B	50.33B
Total operating expenses	44.55B	107.63B	161.36B	111.74B
Operating income	74.57B	13.00B	-55.81B	17.75B
Other non operating income	-	-	-1.64B	-
EBT including unusual items	80.87B	8.74B	-1.20B	18.30B
EBT excluding unusual items	80.87B	8.74B	-51.00B	18.30B
Income tax expense	-6.78B	-80.00M	-383.00M	1.30B
Effective tax rate	-8.39%	-0.92%	32.05%	7.09%
Other operating expenses	-51.30B	-1.10B	50.45B	-337.00M
Net income	87.65B	8.82B	-812.00M	17.00B
Net profit margin	73.58%	7.31%	-0.77%	13.13%
Earnings per share	-	-	-	-
Interest and investment income	5.11B	258.00M	4.64B	2.20B
Interest expense	-	-5.14B	-	-2.09B
Net interest expenses	5.11B	-4.88B	4.64B	107.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	79.85B	18.32B	-52.48B	22.65B
Gain or loss from assets sale	1.96B	-	-	-

Finance

Ask anything